Comment by
Davepark5 on Dec 09, 2022 4:54pm
What the heck does this have to do with ONCY? stop posting unrelated junk
Comment by
Noteable on Dec 09, 2022 5:43pm
Very unfortunately some don't understand ADCs versus Bispecifics and both of their involvements with checkpoint inhibitors and where ONCY'S pelareorep benefits in the spectrum of immuno-oncology combination therapy. Instead they just keep barking at shadows through the window.
Comment by
Noteable on Dec 09, 2022 5:59pm
Should read: "... where ONCY'S pelareorep benefits them both ...."
Comment by
inthno on Dec 10, 2022 10:38pm
I read the article and a good read. Also a quick take a way is for big pharma, Roche or pfizer or someone to get a hold of pela and quickly as the bar seems to be getting set higher and higher. Still looking for a boyout vs parthership as this would take away any uncertainty down the road and thinking that something willl be done by the AGM at the latest if not earlier.